Supplemental Figure 6 from IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR

MLA

Jin Q. Cheng, et al. Supplemental Figure 6 from IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR. Mar. 2023. EBSCOhost, https://doi.org/10.1158/0008-5472.22412915.v1.

APA

Jin Q. Cheng, Eric B. Haura, Domenico Coppola, Douglas W. Cress, Matthew A. Smith, Donghwa Kim, Yajuan Li, Cheng-Xiong Xu, Xiaowen Ding, Jian-Ping Guo, & Sridevi Challa. (2023). Supplemental Figure 6 from IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR. https://doi.org/10.1158/0008-5472.22412915.v1

Chicago

Jin Q. Cheng, Eric B. Haura, Domenico Coppola, Douglas W. Cress, Matthew A. Smith, Donghwa Kim, Yajuan Li, et al. 2023. “Supplemental Figure 6 from IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non–Small Cell Lung Cancer with Activating Mutations of EGFR,” March. doi:10.1158/0008-5472.22412915.v1.